title: [WT1 peptide-based immunotherapy for the treatment of malignancies: focusing on hematological neoplasms].
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Oka
authors.forename: Akihiro
authors.initials: A
authors.lastname: Tsuboi
authors.forename: Sumiyuki
authors.initials: S
authors.lastname: Nishida
authors.forename: Naoki
authors.initials: N
authors.lastname: Hosen
authors.forename: Jun
authors.initials: J
authors.lastname: Nakata
authors.forename: Yoshiko
authors.initials: Y
authors.lastname: Hashii
authors.forename: Tetsuo
authors.initials: T
authors.lastname: Maeda
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Oji
authors.forename: Atsushi
authors.initials: A
authors.lastname: Kumanogoh
authors.forename: Haruo
authors.initials: H
authors.lastname: Sugiyama
mesh_terms: D019496:Cancer Vaccines / Q000627:therapeutic use*; D019337:Hematologic Neoplasms / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000639:trends; D012449:Safety; D016896:Treatment Outcome; D022223:Vaccines, Subunit / Q000627:therapeutic use*; D025721:WT1 Proteins / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D019496:Cancer Vaccines; D022223:Vaccines, Subunit; D025721:WT1 Proteins